Probing for a deeper understanding of rhabdomyosarcoma: insights from complementary model systems.
Probing for a deeper understanding of rhabdomyosarcoma: insights from complementary model systems.
复制标题
DOI:
10.1038/nrc3961
复制
发表时间:
2015-07
期刊:
影响因子:
--
通讯作者:
Galindo RL
中科院分区:
文献类型:
--
作者:
Kashi VP;Hatley ME;Galindo RL
Rhabdomyosarcoma (RMS) is a mesenchymal malignancy composed of neoplastic primitive precursor cells that exhibit histological features of myogenic differentiation. Despite intensive conventional multimodal therapy, patients with high-risk RMS typically suffer from aggressive disease. The lack of directed therapies against RMS emphasizes the need to further uncover the molecular underpinnings of the disease. In this Review, we discuss the notable advances in the model systems now available to probe for new RMS-targetable pathogenetic mechanisms, and the possibilities for enhanced RMS therapeutics and improved clinical outcomes.